A three-finger pinch of salt, a fistful of gur – a sort of unrefined sugar or molasses – in half a litre of water; this simple concoction revolutionized the treatment of diarrhoea in Bangladeshi children in the 1980s. Oral rehydration therapy (ORT), in its various guises, has since become a major tool in the … Continue reading Chowdhury champions constant learning, evaluation and innovation in research
If all goes well, the first malaria drug developed by Thai researchers could reach human clinical trials at the beginning of next year. The drug, dubbed P218, is the product of research carried out by a group at BIOTEC, a research centre created by the Thai government to generate biotechnology innovations. Although several international partners, … Continue reading BIOTEC leads Thailand’s leapfrog towards self-sufficiency
There is a river which runs through Goundry, a village in rural Burkina Faso, West Africa.Actually it's more of a stream with lots of exposed riverbed even as the rainy season finishes. And among the still pools of mustard-coloured water, if you look closely enough, you can see the darting of tiny mosquito larvae. … Continue reading Guardian Development Competition Longlist: Bed nets for all?
Peter Ndumbe was working in London when the new HIV virus began to emerge in the early eighties. One of the multitude of scientists trying to understand the pathogen, he focused on hepatitis and its possible links to the new virus See the rest of the story here.
With several efforts underway to increase the local production of drugs in developing countries, Tatum Anderson assesses the pros and cons of manufacturing medicines in AfricaSee the rest of the story here
Scidev.net 22 March 2010 A landmark decision to allow free access to key earth observation data has failed to impact Africa sufficiently because of poor internet connections, say researchers more>>
17 March 2010A collaboration, called the Open Source Drug Discovery Foundation (OSDD), plans to use voluntary and open efforts to accelerate the development of affordable drugs for diseases including malaria, leishmaniasis and – first – tuberculosis. Few if any new drugs have been created for many of these diseases, because they disproportionately affect the poor … Continue reading Open source: the way forward in the search for new treatments for the infectious diseases of poverty?